Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts (original) (raw)

• Uusitupa, M.I., Niskanen, L.K., Siitonen, O., Voutilainen, E. & Pyorala, K. Five-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and non-diabetic subjects. Circulation 82, 27– 36 (1990).
  CAS PubMed Google Scholar
• Manson, J.E. et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 151, 1141–1147 ( 1991).
  CAS PubMed Google Scholar
• Kannel, W.B., & McGee, D.L. Diabetes and cardiovascular disease: The Framingham Study. J. Am. Med. Assoc. 241, 2035–2038 (1979).
  CAS Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977– 986 (1993).
• Ruderman, N., Williamson. J. & Brownlee, M. Glucose and diabetic vascular disease. FASEB J 6, 2905–2914 ( 1992).
  CAS PubMed Google Scholar
• Brownlee, M., Cerami, A. & Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315–1320 (1988).
  CAS PubMed Google Scholar
• Schmidt, A.M. et al. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987– 14997 (1992).
  CAS PubMed Google Scholar
• Neeper, M. et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998–15004 (1992).
  CAS PubMed Google Scholar
• Wautier, J-L. et al. Advanced glycation endproducts (AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA 91, 7742–7746 (1994).
  CAS PubMed PubMed Central Google Scholar
• Schmidt, A-M. et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1): a potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96, 1395–1403 (1995).
  CAS PubMed PubMed Central Google Scholar
• Miyata, T. et al. The Receptor for Advanced Glycation Endproducts (RAGE) mediates the interaction of AGE-ß2-Microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 98 , 1088–1094 (1996).
  CAS PubMed PubMed Central Google Scholar
• Schmidt, A.M. et al. The receptor for Advanced Glycation Endproducts (AGEs) has a central role in vessel wall interactions and gene activation in response to AGEs in the intravascular space. Proc. Natl. Acad. Sci. USA 91, 8807–8811 ( 1994).
  CAS PubMed PubMed Central Google Scholar
• Wautier, J-L. et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability. J. Clin. Invest. 97, 238– 243 (1996).
  CAS PubMed PubMed Central Google Scholar
• Nishina, P.M., Verstufyt, J. & Paigen, B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid. Res. 31, 859– 869 (1990).
  CAS PubMed Google Scholar
• Kunjathoor, V.V., Wilson, D.L. & LeBoeuf, R.C. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97, 1767 –1773 (1996).
  CAS PubMed PubMed Central Google Scholar
• Zhang, S., Reddick, R.L., Piedrahita, J.A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468–471 (1992).
  CAS PubMed Google Scholar
• Plump, A.S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 ( 1992).
  CAS PubMed Google Scholar
• Like, A.A. & Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417 (1976).
  CAS PubMed Google Scholar
• Dahlquist, G. et al. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Diabetes Care 5, 399–403 (1982).
  CAS PubMed Google Scholar
• Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L. & Ross, R. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 141, 133–140 (1994).
  Google Scholar
• Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. & Williams, R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231– 240 (1987).
  CAS PubMed Google Scholar
• Schmidt, A.M., Yan, S.D. & Stern, D. The Dark Side of Glucose. Nature Medicine 1, 1002–1004 (1995).
  CAS PubMed Google Scholar
• Palinski, W. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15, 571–582 (1995).
  CAS PubMed Google Scholar
• Palinski, W. et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14, 605–616 (1994).
  CAS PubMed Google Scholar
• Gown, A.M., Tsukada, T. & Ross, R. Human atherosclerosis: II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125: 191–207 (1986).
  CAS PubMed PubMed Central Google Scholar
• Yan, S-D. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J. Biol. Chem. 269, 9889–9897 (1994).
  CAS PubMed Google Scholar
• Lander, H.L., Tauras, J.M., Ogiste, J.S., Moss, R.A. & Schmidt, A.M. Activation of the Receptor for Advanced Glycation Endproducts triggers a MAP Kinase pathway regulated by oxidant stress. J. Biol. Chem. 272, 17810 –17814 (1997).
  CAS PubMed Google Scholar
• Morel, D.W. & Chisolm, G.M. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res. 30, 1827–1834 ( 1989).
  CAS PubMed Google Scholar
• Berliner, J.A. & Heinecke, J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20, 707–727 (1996).
  CAS PubMed Google Scholar
• Wilson, P.W.F., Cupples L.A. & Kannel, W.B. Is hyperglycemia associated with cardiovascular disease? The Framingham study. Am. Heart J. 121, 586–590 (1991).
  CAS PubMed Google Scholar
• Jarrett, R.J. The cardiovascular risk associated with impaired glucose tolerance. Diabet. Med. 13 (3 Suppl 2), S15–19 (1996).
  CAS PubMed Google Scholar
• Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292–296 (1997).
  CAS PubMed Google Scholar
• Li, Y.M. et al. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl. Acad. Sci. USA 93, 11047–11052 (1996).
  CAS PubMed PubMed Central Google Scholar
• Havel, R.J., Eder, H.A. & Bragdon, J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345–1353 (1995).
  Google Scholar
• Esterbauer, H., Gebicki, J., Puhl, H. & Jurgens, G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13, 341–390 (1992).
  CAS PubMed Google Scholar
• Tangirala, R.K. et al. Effect of the antioxidant _N,N'_-Diphenyl 1,4-Phenylenediamine (DPPD) on atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 15, 1625–1630 (1995).
  CAS PubMed Google Scholar